Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-27

Clinical Trial Update: Hypertension, Brain Clearance, and Markers of Neurodegeneration

View source ↗

Summary

A completed clinical trial investigates hypertension, brain clearance, and markers of neurodegeneration in people with mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Mild Cognitive Impairment, Hypertension | Status: COMPLETED